Could Low Testosterone Be Undermining Your Heart Health Without You Knowing?
Emerging reviews link low testosterone with higher cardiovascular risks — and natural support may help.
For years, testosterone was viewed mainly as the driver of energy and virility — but recent cardiovascular reviews tell a different story. Low testosterone is increasingly being linked to higher rates of coronary artery disease and vascular inflammation.
Clinical data adds nuance:
- In the TRAVERSE trial (conducted in UK and US), men aged 45–80 with hypogonadism showed no increase in major adverse cardiovascular events when using testosterone replacement therapy. The study even noted a slight, non-significant reduction in all-cause mortality.
- A meta-analysis of randomized trials involving nearly 3,000 men found a 54% increase in cardiovascular-related events among those using TRT — particularly evident in studies not funded by pharmaceutical companies.
Contrastingly, the FDA updated labeling guidelines in 2025, highlighting that recent trials show no significant heightened cardiovascular risk for hypogonadal men using testosterone therapy — while noting possible blood pressure effects.
This complex and sometimes contradictory evidence underscores one point: while restoring testosterone in clinical cases may benefit heart health, synthetic hormone therapy isn’t risk-free. That’s why many UK men are exploring natural testosterone support first.
Supplements like T-Vitality combine clinically studied ingredients — maca root, ginseng, ginkgo biloba — offering a natural route to balanced testosterone without injections or known cardiovascular risks.
This special report explores why thousands in the UK are choosing T-Vitality as their first step toward better heart and hormone health. Read the full story here — [Click Here]
